Results from mendelian randomisation and multivariable adjusted analyses only including limited health conditions (cancer, cardiovascular disease, cerebrovascular disease, and type... by Sean Harrison (1906282)

Receiver operating characteristic (ROC) curves. by Dandan Gong (5744666)

“…The optimal cut-off point of the CD4⁺ count was 50 Nr/μl or less. Among the 350 patients received both fungal culture and Mp1p antigen detection, 95/350 (27.1%) patients were culture-positive for a <i>Talaromyces marneffei</i>, 75/350 (21.4%) patients were Mp1p antigen positive. …”

Cut-point analysis using Youden’s J Index. by Dandan Gong (5744666)

“…The optimal cut-off point of the CD4⁺ count was 50 Nr/μl or less. Among the 350 patients received both fungal culture and Mp1p antigen detection, 95/350 (27.1%) patients were culture-positive for a <i>Talaromyces marneffei</i>, 75/350 (21.4%) patients were Mp1p antigen positive. …”

Anti-cancer effects of combined TC extract and cisplatin. by Napat Armartmuntree (20571035)

LncRNA NORAD engages in psoriasis by binding to miR-26a to regulate keratinocyte proliferation by Shuiqi Li (10426496)

Region and cell microscopy. by Shuk C. Tsoi (21192243)

Young aphasia case study: Source localisation results of the context effect (constrained vs unconstrained naming) in A. and control by Vitoria Piai (9547418)

“…Corresponding Cohen’s d maps (bottom two rows) for control (third row) and A. (fourth row) were thresholded at ±0.2. …”

Preparation of Heat-Denatured Macroaggregated Albumin for Biomedical Applications Using a Microfluidics Platform by Tullio V. F. Esposito (8900282)

“…These microparticles are formed by heat-denaturing albumin in a bulk solution, making it very challenging to control the size and dispersity of the preparations (coefficient of variation, CV, ∼50%). …”

Preparation of Heat-Denatured Macroaggregated Albumin for Biomedical Applications Using a Microfluidics Platform by Tullio V. F. Esposito (8900282)

“…These microparticles are formed by heat-denaturing albumin in a bulk solution, making it very challenging to control the size and dispersity of the preparations (coefficient of variation, CV, ∼50%). …”

<i>WDR5</i> Expression Is Prognostic of Breast Cancer Outcome by Xiaofeng Dai (793874)

“…<div><p>WDR5 is a core component of the human mixed lineage leukemia-2 complex, which plays central roles in ER positive tumour cells and is a major driver of androgen-dependent prostate cancer cell proliferation. …”

FOXD3 expression in HGG tissues and glioma cell lines. by Wei Du (88790)

Forest plot of the second endpoint of the clinical symptom improvement. by Jin-Min Gu (17915039)

DataSheet1_Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis.docx by Lin Zhang (8926)

“…ULT did not ameliorate eGFR slopes (WMD 0.36 ml/min/1.73 m² per year, 95% CI: −0.31, 1.04), or lead to reductions in kidney events (RR 1.26; 95% CI: 0.80, 2.00) or all-cause mortality (RR 1.00; 95% CI: 0.65, 1.55), although ULT resulted in a decrease in serum uric acid levels (WMD −2.73 mg/dl; 95% CI: −3.18, −2.28) and lowered the incidence of gout episodes (0.9 vs 2.7%, RR 0.38; 95% CI: 0.17, 0.86).…”

Criteria for classifying pTRG and mrTRG. by Yaqi Wang (1555240)

Subjects:

Recurrence risk assessment of LARC patients undergoing nCRT by ctDNA monitoring. by Yaqi Wang (1555240)

Subjects:

S3 Fig - by Yaqi Wang (1555240)

Subjects:

Detectability at baseline was not associated with the response to nCRT and patient prognosis. by Yaqi Wang (1555240)

Subjects:

Baseline mutation landscape. by Yaqi Wang (1555240)

Subjects:

Study design, sample collection, study objectives, and work scheme of the present study. by Yaqi Wang (1555240)

Subjects:

Clearance of baseline HRR and HMT mutations during nCRT. by Yaqi Wang (1555240)

Subjects: